Jefferies analyst David Steinberg bumped estimates and his price target on Buy-rated Amphastar Pharmaceuticals (NASDAQ: AMPH) to $15.00 (from $14.00) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE